Pharmacist Counter-Terrorism Preparedness Module 2: Focusing on Potential Bacterial Weapons

Faculty

Needs Statement

Since most experts predict there will be bioterrorism attacks and they may in fact come sooner rather than later, the United States Health Care System must be prepared to care for patients who are both injured but to also care for citizens in the locality who have been exposed to various agents of bioterrorism. This program is designed to help individual clinicians to be better prepared to fully participate in these efforts. All healthcare systems, including both the public and private sector, need to fully cooperate and coordinate their preparation activities in their geographical area to insure maximal preparedness. A working knowledge of each of the possible bioterrorism agents is necessary to accomplish this goal.

Target Audience

Pharmacists, healthcare workers

Objectives

1. Identify bacterial pathogens likely to be used in bioterrorism acts;
2. Understand the CDC categories of Bioterrorism Agents;
3. Identify currently available antimicrobial agents active against likely bioterrorism agents;
4. Understand the adverse effects of antimicrobial agents likely to be needed in the event of a bioterrorist attack;
5. Review experience with antimicrobial agents used in recent anthrax attacks.

Accreditation

Pharmacy
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity has been assigned ACPE # 022-000-06-076-H04 and will award up to 1.00 contact hours (0.1 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of credit will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at conclusion of the activity. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Faculty Disclosure

Professor Rapp is on the Paid Speakers Bureau, has received research contracts and/or grants from, and has received consultation fees from Wyeth Pharmaceuticals, Pfizer Pharmaceuticals, Aventis Pharmaceuticals, and Ortho McNeil Pharmaceuticals.